Jinan Hongyuan Chemical Co.,Ltd

Jinan Hongyuan Chemical Co.,Ltd

info@hychem-china.com

86-13954187575

Jinan Hongyuan Chemical Co.,Ltd
Casa> Blog> Sinopharm Hyundai's "universal antioxidant" lipoic acid API was approved in India and South Korea

Sinopharm Hyundai's "universal antioxidant" lipoic acid API was approved in India and South Korea

January 05, 2022
Beijing News (Reporter Zhang Zhaohui) On December 15th, Sinopharm Hyundai announced that its wholly-owned subsidiary Sinopharm Weiqida's lipoic acid APIs have obtained the API registration certificates of India and South Korea.

Lipoic acid is a powerful new antioxidant, also known as a universal antioxidant. It can support the activity of glucose in human cells, has a strong antioxidant effect, can remove free radicals in the body, and protect the health of the heart and other internal organs. The PDB database shows that in 2020, global sales of lipoic acid preparations will be USD 540.5 million. The main domestic manufacturers of lipoic acid APIs include Suzhou Fujilai Pharmaceutical Co., Ltd. and Jiangsu Tonghe Pharmaceutical Co., Ltd. etc.

Sinopharm Hyundai stated that the overseas registration certificate for lipoic acid this time indicates that the API product can be sold in the Indian and South Korean markets, and will have a positive impact on the further expansion of the international market.
Entre em contato conosco

Author:

Ms. Yi

Phone/WhatsApp:

+8618888297294

Produtos populares
Notícias
Notícias da Indústria
You may also like
Related Categories

Enviar e-mail para este fornecedor

Assunto:
E-mail:
mensagem:

Your message must be betwwen 20-8000 characters

Entre em contato conosco

Author:

Ms. Yi

Phone/WhatsApp:

+8618888297294

Produtos populares
Notícias
Notícias da Indústria

Casa

Product

Whatsapp

Sobre nós

Inquérito

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

enviar